Routine blood tests and severity of COVID-19 infection (search done on 20 March 2020)
Citation: Zeng F, Li L, Zeng J, et al. Can we predict the severity of COVID-19 with a routine blood test? Polish archives of internal medicine. 2020 May 29;130(5):400-6.
What is this? Routine blood tests might provide information about the severity of COVID-19 for an infected patient.
In this rapid review, the authors searched for studies assessing the relationship between the results of routine blood tests and the severity of COVID-19 infection.They restricted their searches to articles published in English and Chinese and did the search on 20 March 2020. They identified 15 studies (3090 patients), all from China.
What was found: At the time of the review, the included studies noted that patients with severe COVID-19 infection more often had higher neutrophil levels, and neutrophil-lymphocyte ratio (NLR), and lower lymphocyte levels, than patients with less severe infection; but that these findings are uncertain.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.